AroCell AB (AROC) — Cash Flow-to-Debt Ratio
AroCell AB (AROC) has a Cash Flow-to-Debt Ratio of -0.08x as of March 2025, meaning its operating cash flow of Skr-1.11 Million could theoretically repay 0% of its total liabilities (Skr14.01 Million) in one year. Check cash flow reinvestment rate of AroCell AB to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
AroCell AB Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for AroCell AB across 11 annual periods. Also explore AroCell AB assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for AroCell AB (2011–2024)
Year-by-year debt coverage analysis for AroCell AB. For market capitalisation and broader financial context, see market value of AroCell AB.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.18x | Skr-2.36 Million | Skr12.93 Million | ▲ +84.7% |
| 2023 | -1.19x | Skr-13.44 Million | Skr11.25 Million | ▼ -16.2% |
| 2022 | -1.03x | Skr-13.69 Million | Skr13.32 Million | ▲ +63.7% |
| 2021 | -2.83x | Skr-28.21 Million | Skr9.96 Million | ▲ +36.8% |
| 2020 | -4.48x | Skr-18.90 Million | Skr4.22 Million | ▼ -226.6% |
| 2019 | -1.37x | Skr-15.06 Million | Skr10.97 Million | ▲ +75.7% |
| 2018 | -5.65x | Skr-16.41 Million | Skr2.90 Million | ▼ -5.1% |
| 2017 | -5.37x | Skr-15.24 Million | Skr2.84 Million | ▼ -122.3% |
| 2016 | -2.42x | Skr-7.17 Million | Skr2.97 Million | ▲ +56.8% |
| 2015 | -5.59x | Skr-9.13 Million | Skr1.63 Million | ▼ -378.6% |
| 2011 | -1.17x | Skr-2.59 Million | Skr2.22 Million | — |